Atlas Trials

Hidradenitis Suppurativa Phase 2b Study of Izokibep

Clinical trial NCT05355805 · COMPLETED

Trial details

NCT number
NCT05355805
Sponsor
ACELYRIN Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2022-05-05
Primary completion
2023-08-02
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.